Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol
Kuŝić, M.; Gavrilović, M.; Mihajloviĉ, M.; Boŝković, B.
Srpski Arhiv Za Celokupno Lekarstvo 108(9): 875-881
1980
ISSN/ISBN: 0370-8179 PMID: 7302695 Document Number: 167667
Document emailed within 1 workday
Related Documents
Matsuura, F. 2007: Familial hyperlipoproteinemia, type IV Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 326-328Di Gruttola, G.; Ferrara, M. 1977: Familial congenital type IIB hyperlipoproteinemia La Pediatria 85(3): 435-442
Andersen, G.E.; Friis-Hansen, B. 1976: Neonatal diagnosis of familial type Ii hyperlipoproteinemia Pediatrics 57(2): 214-220
Traurig, J.; Sobra, J.; Kvasilová, M.; Wildtová, Z. 1978: Familial hyperlipoproteinemia type IIA with homozygotic manifestations in a heterozygote Vnitrni Lekarstvi 24(7): 684-690
Arranz Peña, M.L.; Alonso de la Peña, M.C. 1985: Hyperlipoproteinemia type I. Study of a familial deficiency of lipoprotein-lipase Revista Clinica Espanola 176(2): 98-100
Koffigan, M.; Fruchart, J.C.; Dhondt, J.L.; Moschetto, Y.; Farriaux, J.P. 1982: Apolipoprotein B measurement in blood spotted on paper (a screening test for familial type II A hyperlipoproteinemia) La Ricerca in Clinica E in Laboratorio 12(1): 169-172
Sakae, N.; Taniwaki, T.; Arakawa, K.; Yamada, T.; Kira, J. 2000: A case of familial type IIa hypercholesterolemia with the clinical features similar to cerebrotendinous xanthomatosis Rinsho Shinkeigaku 40(3): 222-226
Wilson, J.M.; Chowdhury, J.R. 1990: Prospects for gene therapy of familial hypercholesterolemia Molecular Biology and Medicine 7(3): 223-232
Shiomi, M.; Ito, T.; Watanabe, Y. 1987: Hypercholesterolemia and atherosclerosis in the WHHL rabbit, an animal model of familial hypercholesterolemia Progress in Clinical and Biological Research 229: 35-40
Schwartzkopff, W.; Schilling, A.; Calder, D. 1980: Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard Die Medizinische Welt 31(14): 515-520
Krapivner, S.R.; Malyshev, P.P.; Rozhkova, T.A.; Potaraus, A.B.; Kukharchuk, V.V.; Bochkov, V.N. 2000: Application of DNA analysis for differential diagnosis of familial hypercholesterolemia and familial defect of apolipoprotein b-100 Terapevticheskii Arkhiv 72(4): 9-12
Bourbon, M.; Rato, Qéria. 2006: Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 25(11): 999-1013
Wessels, G. 1977: Hyperlipoproteinemia type V Fredrickson. a rare metabolic disorder, its diagnosis and therapy, as demonstrated on an own case Die Medizinische Welt 28(3): 136-137
Jansen, S.; Zambrana, J.L.; López Miranda, J.; Blanco, A.; Blanco, J.; Jiménez Perepérez, J.A.; Espino, A.; Pérez Jiménez, F. 1995: Possible relationship between overweightness and prevalence of hyperlipemia in the children of patients with heterozygote familial hypercholesterolemia and combined familial hyperlipemia Medicina Clinica 105(3): 85-88
De Gennes, J.L. 1988: Genetic studies in familial hyperlipoproteinemia, and therapeutic implications Annales de Biologie Clinique 46(1): 1-3
Lahoz, C.; Mostaza, J.M. 1999: Familial hypercholesterolemia. Are we different in this also? Medicina Clinica 113(14): 533-534
Widhalm, K. 2000: Familial hypercholesterolemia Deutsche Medizinische Wochenschrift 125(4): 99
Bolzano, K.; Krempler, F.; Schellenberg, B.; Schlierf, G. 1979: A comparison of bezafibrate and clofibrate in type Ii B and type IV hyperlipoproteinemia Acta Medica Austriaca 6(3): 90-94
Arntz, H.R.; Klemens, U.H.; Vollmar, L.J.; Lang, P.D. 1978: Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia Medizinische Klinik 73(49): 1731-1737
Cariou, B.; Krempf, M. 2011: Screening for familial hypercholesterolemia La Revue du Praticien 61(8): 1106-1107